DANIEL G WELCH
CIK 1206199 · Chairman, CEO and President · last filed 2026-05-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$6.29M
Companies
8
Total Filings
108
Lifetime Open-Market Net
-$34.94M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RARE | Director | 40,441 | $24.35 | $984.7K | $0 | 13 | 2026-05-18 |
| PRTA | Director | — | $8.25 | — | $0 | 4 | 2026-05-15 |
| GPCR | Director | 123,508 | $42.93 | $5.30M | $0 | 4 | 2025-06-25 |
| Nuvation Bio Inc. (NUVB.WS) Delisted | Director | 659,947 | $0.01 | $3.4K | $0 | 6 | 2024-05-29 |
| Seagen Inc. (SGEN) Delisted | Director | 0 | $228.74 | $0 | -$34.84M | 31 | 2023-12-15 |
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Director | 8,060 | $19.00 | $153.1K | -$102.1K | 8 | 2020-06-01 |
| AveXis, Inc. (AVXS) Delisted | Director | 0 | — | — | $0 | 4 | 2018-05-15 |
| HYPERION THERAPEUTICS INC (HPTX) Delisted | Director | 0 | — | — | $0 | 3 | 2015-05-08 |
Recent Filings · Page 10 of 11
108 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-05-17 | — | Tax (F) | −2,108 | -$80.9K | |
| 2011-05-12 | — | Grant (A) | +32,000 | $0 | |
| 2011-03-24 | — | Sell (S) | −17,440 | -$759.0K | |
| 2011-03-04 | — | Sell (S) | −44,000 | -$1.75M | |
| 2010-12-21 | — | Mixed | −7,522 | -$7.74M | |
| 2010-06-10 | — | Grant (A) | +150,000 | $0 | |
| 2010-05-25 | Seagen Inc. (SGEN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-05-17 | — | Tax (F) | −15,120 | -$155.8K | |
| 2010-03-23 | — | Mixed | −17,260 | -$1.21M | |
| 2009-05-19 | Seagen Inc. (SGEN) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.